In this study, we aimed to estimate the spectrum of SF3B1 mutation-harboring MDS patients in Zhejiang Province of China, to analyze their clinical and laboratory characteristics and molecular landscape, and to explore the prognostic impacts of co-mutations. Here, SF3B1 is linked to myelodysplastic syndrome.